Note: This post is the analysis of the following large trade by us. It is not financial advice. The stock market is risky, and options trade may result in significant loss. Please do your own research before making any trade. Check and agree to full terms on our website before considering this information.
Large Trades
| Ticker | C/P | Strike | Expiration | Price | Size | Premium | Delta | DTE | Condition |
| ABT | Put | 108 | 07/21/23 | $2.37 | 4000 | $948K | -0.51 | 22 | Spread |
About the trade for ABT 2023-07-21 P108
- bid: $2.37, ask: $2.43, trade price: $2.37, trade size: 4000, total premium: $948000.0
- Possible trade type: STO (sell to open).
- Possible trade motivation: ER riding play. Resistance level at 108.
- Note: ER on Jul 20 Pre-market, another leg buying C108.
- Trading Strategy: replicate the large trade with smaller size (sell P108 and buy C108).
- Exit plan: take profit when stock price is near level 112 and level 115.
About the company
- ‘name’: ‘Abbott Laboratories’, ‘country’: ‘US’, ‘finnhubIndustry’: ‘Health Care’, ‘ipo’: ‘1937-03-01’, ‘marketCapitalization’: ‘196031.5M’, ‘shareOutstanding’: ‘1739.0M’
- 2023-06-29 16:21:00 | The Council of State and Territorial Epidemiologists voted to add cronobacter infections to the list of roughly 120 diseases tracked at the national level.
- 2023-06-29 09:35:00 | Shares of Abbott Laboratories inched 0.05% higher to $107.66 Thursday, on what proved to be an all-around great trading session for the stock market, with…
- 2023-06-29 06:00:00 | Abbott (NYSE: ABT) will announce its second-quarter 2023 financial results on Thursday, July 20, before the market opens.
Weekly stock price chart
Daily stock price chart
Update on 2023-07-21
- Stock price rose on ER day and hit high of 114.79 on Jul 21.
- Options expired worthless, leading to 100% gain. (C108 price went from $1.9 to $6.5.)
- 2023-07-21 09:36:00 | Shares of Abbott Laboratories rallied 2.20% to $114.29 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P…
- 2023-07-21 09:18:00 | Pharmaceutical biggie and medical device maker Abbott Laboratories has been mapping out a base pattern on the charts for months now. The On-Balance-Volume (OBV) line shows really good strength from March and tells me that buyers of ABT have been more aggressive than sellers.
- 2023-07-21 08:41:24 | Abbott says it is back on track to dominate the baby formula market after recall in 2022.
- 2023-07-21 06:46:13 | Abbot upgraded, Carvana downgraded: Wall Street’s top analyst calls
Daily stock price chart
Options contract price chart
